Primacor IV
FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease »
"The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked a"...
Read the FDA Approves First Drug-Eluting Stent to Treat Peripheral Arterial Disease article »
Primacor IV
Primacor IV Patient Information including How Should I Take
In this Article
- What is milrinone (Primacor IV)?
- What are the possible side effects of milrinone (Primacor IV)?
- What is the most important information I should know about milrinone (Primacor IV)?
- What should I discuss with my healthcare provider before I receive milrinone (Primacor IV)?
- How is milrinone given (Primacor IV)?
- What happens if I miss a dose (Primacor IV)?
- What happens if I overdose (Primacor IV)?
- What should I avoid after receiving milrinone (Primacor IV)?
- What other drugs will affect milrinone (Primacor IV)?
- Where can I get more information?
What should I discuss with my healthcare provider before I receive milrinone (Primacor IV)?
You should not receive this medication if you are allergic to milrinone, or if you have recently had a heart attack.
If possible before you receive milrinone, tell your doctor if you have a heart rhythm disorder or low levels of potassium in your blood (hypokalemia).
FDA pregnancy category C. It is not known whether milrinone is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether milrinone passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
In an emergency situation, it may not be possible before you are treated with milrinone to tell your caregivers if you are pregnant or breast-feeding. However, make sure any doctor caring for your pregnancy or your baby knows that you have received this medication.
How is milrinone given (Primacor IV)?
Milrinone is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. Milrinone is usually given around-the-clock for up to 48 hours.
Your heart rate and blood pressure will be constantly monitored while you are being treated with milrinone. Your kidney function and electrolytes may also need to be checked with blood tests.
Additional Primacor IV Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Heart Health
Get the latest treatment options.
Updated & New
